TICKERNERD
Menu
CAHCAHHealthcare · Medical Distribution

CAH Stock Forecast: Cardinal Health, Inc. Price Predictions for 2026-2027

Last close, 11 Aug 2026
$240
+1.30% on the day

The 17 Wall Street analysts covering Cardinal Health, Inc. hold a median 12-month price target of $258 — +7.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 94 of 100 as at 10 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$55.4B
Ticker Nerd rank
94 / 100
Median analyst target
$258
Analysts covering
17
Total return, dividends reinvested
1W
+2.9%
1M
+1.9%
YTD
+17.7%
1Y
+54.0%
From 52W high
0.0%
From 52W low
+66.2%
$145
$240
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CAH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Cardinal Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 10 Aug 2026
94 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
96
Momentum
94
Quality
87
Value
85
Revisions
79
Growth
68
Issuance
64
Accruals
61
Size
5

Volatility (96): The share price has been relatively steady.

Accruals (61): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (5): Larger than most of the companies we track — more scrutinised, less often mispriced.

Wall Street

CAH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CAH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$150$200$250$300Oct 25Jan 26Apr 26Jul 26CAHHigh $275Median $258Low $215

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says17 analysts
14 Buy3 Hold0 Sell
Low $215Median $258High $275

The green dot is the last close — the median target sits +7.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
24 July 2026CitigroupMaintainsBuy$245 → $265
23 July 2026MizuhoMaintainsOutperform$235 → $240
20 July 2026UBSMaintainsBuy$260 → $274
9 July 2026TD CowenMaintainsBuy$255 → $275
9 July 2026TD CowenMaintainsBuy—
2 July 2026B of A SecuritiesMaintainsBuy$240 → $260
2 July 2026B of A SecuritiesMaintainsBuy—
4 May 2026JP MorganMaintainsNeutral—
1 May 2026CitigroupMaintainsBuy—
1 May 2026TD CowenMaintainsBuy—
1 May 2026Wells FargoMaintainsOverweight—
28 Apr 2026William BlairInitiatesOutperform—
8 Apr 2026Evercore ISI GroupMaintainsOutperform—
24 Feb 2026BarclaysMaintainsOverweight—
10 Feb 2026JP MorganMaintainsNeutral—
10 Feb 2026Wells FargoMaintainsOverweight—
6 Feb 2026MizuhoMaintainsOutperform—
29 Jan 2026Morgan StanleyMaintainsOverweight—
15 Jan 2026Wells FargoMaintainsOverweight—
9 Jan 2026CitigroupUpgradeBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CAH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CAH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Cardinal Health, Inc. (CAH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
36.0×

Cheaper than 22% of US stocks

Price / sales
0.2×

Cheaper than 92% of US stocks

Price / book
−20.9×

Cheaper than 98% of US stocks

EV / EBITDA
15.1×

Cheaper than 24% of US stocks

Growth & margins
Revenue growth (YoY)
11.0%

Higher than 55% of US stocks

Earnings growth (YoY)
−21.1%

Higher than 19% of US stocks

Gross margin
4.1%

Higher than 6% of US stocks

Operating margin
1.4%

Higher than 48% of US stocks

Net margin
0.6%

Higher than 48% of US stocks

Returns & dividend
Return on equity
−59.3%

Higher than 19% of US stocks

Return on assets
3.6%

Higher than 69% of US stocks

Dividend yield
0.9%

Higher than 20% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CAH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Distribution
CompanyMarket capTKN rank
CAHCardinal Health, Inc.$55.4B
94
CORCencora, Inc.$63.0B
71
MCKMcKesson Corp.$103.0B
87
HSICHenry Schein, Inc.$10.1B
23
EWEdwards Lifesciences Corp.*$53.0B
91
BDXBecton, Dickinson & Co.*$49.5B
91
IDXXIDEXX Laboratories, Inc.*$47.6B
85

* Nearest Healthcare names by size — few medical distribution companies of this scale trade in the US universe.

The rank is the raw material. Whether the rules would actually own Cardinal Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CAH news & analysis

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Zacks Investment Research · 11 Aug 2026positive

Cardinal Health beat fiscal Q4 earnings-per-share estimates on strong pharmaceutical segment performance, though revenues fell short of expectations. The company also issued fiscal 2027 guidance indicating continued earnings growth.

Why it matters — A CAH watcher would care because the earnings beat and positive forward guidance signal underlying strength in Cardinal Health's core pharma business despite the revenue miss.

Cardinal Health Q4 Earnings Call Highlights

MarketBeat · 11 Aug 2026positive

Cardinal Health reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings, and adjusted earnings per share. The growth was supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment.

Why it matters — A Cardinal Health watcher would care because the quarter shows broad earnings growth driven by its pharmaceutical, specialty, and medical segments.

Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call Transcript

Seeking Alpha · 11 Aug 2026neutral

Cardinal Health, Inc. (CAH) released its Q4 2026 earnings call transcript, as published by Seeking Alpha, covering the company's fourth-quarter 2026 earnings discussion. The transcript documents management's remarks during the earnings call.

Why it matters — CAH watchers would look to this transcript for management's perspective on the company's quarterly financial results and outlook.

Existing Home Sales Data in Focus

Zacks Investment Research · 11 Aug 2026neutral

Pre-market futures are correcting Monday's slight selloff, with the Dow up 71 points, S&P 500 up 16, and Nasdaq up 129. Analysts expect little market movement either direction until inflation reports, beginning with Wednesday's Consumer Price Index, hit the tape.

Why it matters — A CAH watcher would care because broad market and inflation data can influence sentiment and trading conditions affecting healthcare stocks like Cardinal Health.

Small Biz Index, Existing Home Sales & More Earnings

Zacks Investment Research · 11 Aug 2026neutral

The piece notes that little market movement in either direction is expected until inflation reports are released Wednesday morning. Headlined around a small-business index, existing home sales, and additional earnings reports, it points to upcoming data as the likely driver of activity.

Why it matters — A Cardinal Health watcher would care because upcoming inflation data could influence broader market conditions, including the trading environment for the stock, though no company-specific details are provided.

FAQ

Frequently asked questions about CAH stock

What is the CAH stock price forecast for 2026-2027?

The 17 Wall Street analysts covering Cardinal Health, Inc. have a median 12-month price target of $258, with estimates ranging from $215 to $275. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CAH stock a buy right now?

Of the 17 analysts covering Cardinal Health, Inc., 14 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Cardinal Health, Inc. 94 out of 100 across roughly 4,600 US stocks as at 10 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CAH?

As at 10 Aug 2026, Cardinal Health, Inc. ranks 94 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).

Will CAH stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +7.4% from the last close, and Ticker Nerd's factor model ranks Cardinal Health, Inc. 94 out of 100 as at 10 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CAH stock forecast for 2030?

No analyst covering Cardinal Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CAH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $215 to $275 over the next 12 months.

How has CAH stock performed over the past year?

Cardinal Health, Inc. returned +54.0% over the 12 months to 11 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Cardinal Health, Inc. do?

Cardinal Health Inc. is a healthcare services and products company that supports the movement of medicines, medical supplies, and clinical products across the healthcare system.

What is the latest news on CAH?

The most recent item we track (Zacks Investment Research, 11 Aug 2026): "CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up". Cardinal Health beat fiscal Q4 earnings-per-share estimates on strong pharmaceutical segment performance, though revenues fell short of expectations. The company also issued fiscal 2027 guidance indicating continued earnings growth.

Company

About Cardinal Health, Inc.

Cardinal Health Inc. is a healthcare services and products company that supports the movement of medicines, medical supplies, and clinical products across the healthcare system. The company distributes branded, generic, and specialty pharmaceuticals to pharmacies, hospitals, and other healthcare providers, while also supplying medical-surgical products and equipment to facilities in North America, Europe, and Asia. Its offerings include customized solutions for hospitals, health systems, ambulatory surgery centers, clinical laboratories, and physician offices, along with performance and data solutions designed to improve supply chain efficiency. Cardinal Health plays a central role in medical distribution, helping connect manufacturers, providers, and care settings through large-scale logistics and product support. Headquartered in Dublin, Ohio, Cardinal Health is a major participant in the healthcare supply chain and serves a broad range of customers across the industry.

CEO Mr. Jason M. Hollar · 53,084 employees · United States · https://www.cardinalhealth.com